These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18395667)

  • 1. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2007 Dec; 26(4):196-202. PubMed ID: 18395667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aesthetic botulinum A toxin in the mid and lower face and neck.
    Carruthers J; Carruthers A
    Dermatol Surg; 2003 May; 29(5):468-76. PubMed ID: 12752513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cosmetic use of botulinum toxin type B in the upper face.
    Sadick NS
    Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable treatments for the aging face.
    Wise JB; Greco T
    Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A treatment of perioral rhytides.
    Semchyshyn N; Sengelmann RD
    Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
    Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian consensus report on the aesthetic use of onabotulinum toxin A.
    Bertossi D; Cavallini M; Cirillo P; Piero Fundarò S; Quartucci S; Sciuto C; Tonini D; Trocchi G; Signorini M
    J Cosmet Dermatol; 2018 Oct; 17(5):719-730. PubMed ID: 30091253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
    Iozzo I; Tengattini V; Antonucci VA
    J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsurgical correction of drooping mouth corners using monophasic hyaluronic acid and incobotulinumtoxinA.
    Bae GY; Na JI; Park KC; Cho SB
    J Cosmet Dermatol; 2020 Feb; 19(2):338-345. PubMed ID: 31125173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.